Melinda Frame, MD
Obstetrics & Gynecology · Mobile, ALNPI 1548581523
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $10,080 of the $15,721 with a category attached, or 64.1%. Virtual Incision Corporation accounts for 65.2% of it on its own, with 33 other manufacturers making up the rest. 2025 is the largest year on record at $14,106, more than ten times the $162 reported in 2019. Among obstetrics & gynecology clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 121 payments — averaging $129.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Virtual Incision Corporation$10K
- Biogen$2K
- Medical Device Business Services, Inc.$1K
- Intuitive Surgical$521
- Mayne Pharma Commercial LLC$235
- Daiichi Sankyo Inc.$167
- plus $1K from 28 others
What the payments were for
- Consulting fees$10,08064%
- Travel & lodging$3,35821%
- Food & beverage$2,25014%
- Education$330%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Virtual Incision Corporation | 23 | $10,246 |
| Biogen | 1 | $2,080 |
| Medical Device Business Services, Inc. | 7 | $1,189 |
| Intuitive Surgical | 5 | $521 |
| Mayne Pharma Commercial LLC | 8 | $235 |
| Daiichi Sankyo Inc. | 7 | $167 |
| Johnson & Johnson | 4 | $147 |
| AbbVie | 7 | $133 |
| Aspira Women's Health Inc | 2 | $128 |
| Pfizer | 5 | $103 |
| Coopersurgical, Inc. | 5 | $90 |
| Bayer | 4 | $73 |
| Exeltis, USA Inc. | 5 | $68 |
| Sumitomo Pharma America, Inc. | 4 | $61 |
| Mylan Pharmaceuticals Inc. | 4 | $55 |
| Astellas Pharma US Inc | 2 | $44 |
| Organon | 2 | $40 |
| Lupin Inc. | 3 | $37 |
| Eisai Inc. | 2 | $34 |
| Sage Therapeutics, LLC | 2 | $33 |
| Hologic Sales And Service, LLC | 2 | $29 |
| Meditrina | 3 | $26 |
| Shield Therapeutics Inc | 1 | $25 |
| Zyla Life Sciences, Inc. | 1 | $17 |
| Urovant Sciences Inc | 1 | $17 |
| Millicent US Inc | 1 | $16 |
| BD | 1 | $15 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 |
| Amgen | 1 | $14 |
| Avion Pharmaceuticals | 1 | $13 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
| Smith+Nephew | 1 | $13 |
| Myovant Sciences Inc. | 1 | $12 |
| Evofem Biosciences, Inc. | 3 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,721 in reported general payments places this provider in the 95th percentile of 537 obstetrics & gynecology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 34 | $17,906 |
| Estradiol | 176 | $8,840 |
| PremarinEstrogens, Conjugated | 18 | $6,780 |
| Estradiol (Twice Weekly)Estradiol | 45 | $5,352 |
| Risedronate Sodium | 51 | $5,088 |
| ValacyclovirValacyclovir Hcl | 37 | $1,300 |
| DottiEstradiol | 11 | $1,288 |
| Medroxyprogesterone Acetate | 30 | $1,163 |
| Oxybutynin Chloride ErOxybutynin Chloride | 57 | $898 |
| Clobetasol Propionate | 36 | $850 |
| Nystatin-TriamcinoloneNystatin/Triamcinolone Acet | 23 | $535 |
| Fluconazole | 92 | $498 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 28 | $475 |
| Alendronate Sodium | 52 | $428 |
| Paroxetine Hcl | 25 | $373 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $44 | $17,90634 claims |
| PfizerPremarin | $103 | $6,78018 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 537 obstetrics & gynecology providers in Alabama.
Other obstetrics & gynecology in Mobile
- Timothy HughesMobile$149K
- Allison CalhounMobile$132K
- Phillip MadoniaMobile$14K
- Quin BixlerMobile$12K
- Amy McCoyMobile$10K
- Jessica JonesMobile$9K
- Margaret KruegerMobile$7K
- Theodore CatranisMobile$7K
- Lauren LambrechtMobile$6K
- Patton Morrison-BartonMobile$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.